Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 8/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 2/20 | 0.43 |
| ▸ | STS | P08842 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23826716 | 1.00 | GPR119 (0.46) | GPR119DPP4MMP13STSKMT2A | |
| SCHEMBL23826712 | 1.00 | GPR119 (0.46) | GPR119DPP4MMP13STSKMT2A | |
| SCHEMBL23826048 | 0.88 | DPP4 (0.46) | GPR119DPP4MMP13STSKMT2A | |
| SCHEMBL23826051 | 0.88 | DPP4 (0.46) | GPR119DPP4MMP13STSKMT2A | |
| SCHEMBL31336499 | 0.87 | DPP4 (0.48) | GPR119DPP4MMP13STSKMT2A | |
| SCHEMBL23827019 | 0.87 | DPP4 (0.48) | GPR119DPP4MMP13STSKMT2A | |
| SCHEMBL23826456 | 0.87 | DPP4 (0.48) | GPR119DPP4MMP13STSKMT2A | |
| SCHEMBL23826863 | 0.87 | STS (0.40) | GPR119DPP4STSKMT2AMEN1 | |
| SCHEMBL23826314 | 0.87 | STS (0.40) | GPR119DPP4STSKMT2AMEN1 | |
| SCHEMBL23826013 | 0.87 | GPR119 (0.45) | GPR119DPP4MMP13STSKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113302184-B | 1,3, 4-Oxadiazolinone compounds and medicaments | 日本新药株式会社 | 2024-11-22 | — | — | CN | disclosed |